You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Addresses the major side-effects of one of the most widely prescribed drug classes in a light, readable style.
A very readable and well illustrated 1999 clinical guide to the common side effects of antipsychotic medication.
This comprehensive and authoritative resource thoroughly covers the basic science of psychiatry as well as its clinical practice. It succinctly presents all of the information needed for psychiatric certification. The 7th Edition features a new soft-cover binding and a more user-friendly format, as well as an increased focus on evidence-based medicine.
Drug development today needs to balance agility, speed, and risk in defining probability of success for molecules, mechanisms, and therapeutic concepts. New techniques such as fMRI promise to be part of a sequence that could transform drug development. Although numerous review articles exist that discuss the use of imaging in drug development, no one source is available that combines the various techniques and includes a discussion of disease mapping. Imaging in CNS Drug Discovery and Development, Implications for Disease and Therapy will serve to distill the most salient developments in the use of imaging in drug development and disease mapping. It will launch evolving concepts that integrate new imaging technologies and paradigms with molecular medicine and molecular profiling ("monics") as well as consider the ethical issues that arise as a result of disease or state diagnosis and the use of imaging in the public eye.
Despite all research that has been devoted to schizophrenia over the last years, the understanding of the biological bases of the disorder is still fragmentary. Adding to the complexity is the realization that basic cognitive functions are seriously distorted, and that removal of symptoms does not necessarily ameliorate the cognitive deficits. It has also been shown that cognitive deficits can occur before clinical symptoms, in a prodromal phase of the disorder, pointing to a possible causal relationship between cognitive deficits and outbreak of the disorder. However, it is still not possible to diagnose a patient from cognitive deficits alone, or from a combination of clinical symptoms and...
This volume reviews the current state of research within the behavioral pharmacology of 5-HT. The book opens exciting new approaches to the interdisciplinary study of behavior and pharmacology with special reference to ethology, endocrinology, neuroanatomy and comparative aspects of drug action, and notes new developments in therapeutic drugs of the future.
Now in its sixth edition, and written by an author internationally recognised in his field, Psychiatric Drugs Explained offers a wealth of information in a handy easy-to-use format. Organised by disorder, and providing a comprehensive review of drug effects, action and side-effects, this fully updated new edition covers the latest drugs on the market, and explores changes in prescribing practice. The author's approach is distinctive and reader-friendly, to help guide mental health professionals through the benefits and impacts of psychotropic drugs. Additional topics include management of disorders including stimulants and drugs for children, cognitive impairment and sleep disorders. - Inclu...
The book is a compendium of articles from Hospital and Community Psychiatry on tardive dyskinesia.
Early clinical intervention in psychosis is now a major objective of mental health services and the development of specialist intervention services has greatly facilitated research on the early phases of this disorder. In this book, contributors provide a review of the neurobiological research in people at high risk of psychosis, focusing on the transition from being at a high risk state to their first episode. Contributors consider unaffected family members and twin studies as well as the individual’s data before and after the onset of the illness. The environmental factors that contribute to a psychotic episode are also examined. Vulnerability to Psychosis presents neurobiological findings in the context of what is now known about the psychopathology and cognitive impairments that are evident in people at high risk of psychosis. It will be essential reading for clinicians working with this client group, and will interest academics looking for state of the art information in this field.